Clinical Study of Endocardial Myocardial Biopsy

In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Myocarditis Cardiac Tumor Cardiomyopathies Cardiovascular Diseases Endocardiomyocardial Biopsy Heart Diseases Heart Failure Heart Neoplasms Neoplasms Neoplasms by Site Thoracic Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, Zhejiang, China

Location status: Recruiting

Location contact

XiaoHong PAN

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
Have the ability to understand the test, can cooperate with investigators.

Exclusion criteria

Unable to understand or unwilling to fill in informed consent forms or follow visitors.

Treatment and study plan

Endocardiomyocardial biopsy

Procedure

Endocardiomyocardial biopsy

Primary outcomes

Incidence of MACE-4

Time frame: 10 year

incidences of MACE-4(cardiovascular death, myocardial infarction, stroke and hospitalized unstable angina)

Study contacts

Contact information is provided by the study sponsor or research team.

XiaoHong PAN

CONTACT

[email protected]

+8613857116993

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2031
Study completion: 2031
First posted: Feb 8, 2023
Registry last updated: Mar 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting